Clinical Trial Update: Pemetrexed Followed by Docetaxel or in Reverse Sequence [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing pemetrexed followed by docetaxel versus the reverse sequence in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Non-small-cell Lung Cancer | Phase 4 | Status: COMPLETED